[Expression and clinical significance of MMR protein and MLH1 promoter methylation testing in endometrial cancer].

Main|Search|PHGKB




Last Posted: Jan 03, 2019

---

• [Expression and clinical significance of MMR protein and MLH1 promoter methylation testing in endometrial cancer].
  Jin W et al. Zhonghua fu chan ke za zhi 2018 Dec 53(12) 823-830
• Analysis of the Prevalence of Microsatellite Instability in Prostate Cancer and Response to Immune Checkpoint Blockade.
  Abida Wassim et al. JAMA oncology 2018 Dec
• Cancer communication research in the era of genomics and precision medicine: a scoping review.
  Kaphingst Kimberly A et al. Genetics in medicine : official journal of the American College of Medical Genetics 2018 Dec
• Testing strategies to reduce morbidity and mortality from Lynch syndrome.
  Keränen Anne et al. Scandinavian journal of gastroenterology 2018 Dec 1-6
• Current Approaches to Pancreatic Cancer Screening.
  Chhoda Ankit et al. The American journal of pathology 2019 Jan 189(1) 22-35
• Diagnostic and reporting issues of preneoplastic polyps of the large intestine with early carcinoma.
  Snover Dale C et al. Annals of diagnostic pathology 2018 Dec 391-14
• Genetic predisposition to colorectal cancer: syndromes, genes, classification of genetic variants and implications for precision medicine.
  Valle Laura et al. The Journal of pathology 2018 Dec
• Next Generation Sequencing in Molecular Diagnosis of Lynch Syndrome - a Pilot Study Using New Stratification Criteria.
  Kašubová Ivana et al. Acta medica (Hradec Kralove) 2018 61(3) 98-102
• Lynch Syndrome and Death Anxiety 
  G Hurst, Cure today, December 11, 2018
• [Lynch syndrome: genetic, clinical and diagnostic aspects].
  Castro-Mujica María Del Carmen et al. Revista de gastroenterologia del Peru : organo oficial de la Sociedad de Gastroenterologia del Peru 38(3) 265-279

more